| GlaxoSmithKline has set targets for improving environment, health
and safety performance to be reached by the end of 2005, starting
from a baseline set in 2001. These improvement targets are an integral
part of the EHS Plan for Excellence.
We base GlaxoSmithKline's overall EHS improvement targets on information about practical improvement plans and forecasts from all manufacturing operations. We compare proposals for company targets with benchmarking information and our environment, health and safety professionals, senior managers and management teams throughout the business closely review them.
In addition to company targets, each operation has improvement targets based on its own unique EHS profile, which includes local EHS related projects. This means sites can focus their resources on areas of greatest potential impact to environment, health and safety. Sites with the greatest potential impact set the most aggressive reduction targets, while sites with less potential impact set continuous improvement targets. In this way each operation has improvement targets that should result in GlaxoSmithKline's achieving the overall company targets.
In 2003, GlaxoSmithKline implemented a process to reconfirm site commitment to the 2005 targets they set in 2001. We also conducted workshops in which sites shared projects and practices they had implemented to reduce their impacts on the environment. This sharing of best practices will help maintain our progress toward achieving our 2005 targets.
|
